Inactive Instrument

IntelliPharmaCeutics International Inc. Stock OTC Bulletin Board

CA4581733090

Valuation: IntelliPharmaCeutics International Inc.

Market Cap	1.28M 1.12M 1.04M 955K 1.8M 124M 1.83M 12.41M 4.87M 60.45M 4.81M 4.71M 208M	P/E 2021	-0.4x	P/E 2022	-0.91x
Enterprise Value	3.52M 3.09M 2.85M 2.63M 4.95M 340M 5.03M 34.13M 13.38M 166M 13.23M 12.94M 573M	EV / Sales 2021	-	EV / Sales 2022	74x
Free-Float	98.24%	Yield 2021 *	-	Yield 2022	-

* Estimated data More valuation ratios

Managers and Directors: IntelliPharmaCeutics International Inc.

Manager	Title	Age	Since
Amina Odidi DFI	Director of Finance/CFO	-	-
Fazayill Shaideen AUD	Comptroller/Controller/Auditor	-	2007-03-31
Christian Akyempon PRN	Corporate Officer/Principal	-	2014-01-31

Director	Title	Age	Since
Amina Odidi BRD	Director/Board Member	-	2004-08-31

More insiders

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Companyâ€™s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.

Employees

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTELLIPHARMACEUTICS INTERNATIONAL INC.	+6.06%	+14.94%	-	-	1.52M
ELI LILLY AND COMPANY	-2.73%	-2.96%	+48.62%	+147.27%	1,051B
JOHNSON & JOHNSON	-1.67%	-3.47%	+52.00%	+47.77%	609B
ABBVIE INC.	-0.44%	+2.17%	+33.88%	+78.20%	450B
ROCHE HOLDING AG	-0.75%	+0.30%	+28.32%	+21.15%	330B
NOVARTIS AG	-1.52%	-1.19%	+33.38%	+35.35%	284B
ASTRAZENECA PLC	-1.70%	-1.82%	+20.26%	+15.74%	263B
NOVO NORDISK A/S	-0.58%	+1.11%	-20.89%	-40.59%	223B
AMGEN INC.	-0.58%	+1.03%	+23.55%	+56.14%	198B
GILEAD SCIENCES, INC.	-0.80%	+1.38%	+23.09%	+66.64%	167B
Average	-0.08%	-0.16%	+26.91%	+47.52%	397.23B
Weighted average by Cap.	-0.89%	-1.07%	+35.25%	+70.88%

	2021	2022
Net sales	-	65.73K 57.61K 53.25K 48.98K 92.41K 6.34M 93.89K 637K 250K 3.1M 247K 241K 10.68M
Net income	-5.15M -4.51M -4.17M -3.83M -7.23M -496M -7.35M -49.84M -19.54M -243M -19.32M -18.9M -836M	-2.89M -2.54M -2.34M -2.16M -4.07M -279M -4.13M -28.02M -10.98M -136M -10.86M -10.62M -470M
Net Debt	1.15M 1M 928K 853K 1.61M 110M 1.64M 11.1M 4.35M 54.04M 4.3M 4.21M 186M	2.24M 1.97M 1.82M 1.67M 3.15M 216M 3.2M 21.72M 8.52M 106M 8.42M 8.24M 364M

IntelliPharmaCeutics International Inc. Stock OTC Bulletin Board

Stocks

CA4581733090

Pharmaceuticals

Valuation: IntelliPharmaCeutics International Inc.

Quotes and Performance

Managers and Directors: IntelliPharmaCeutics International Inc.

Other Pharmaceuticals

Financials

Company Profile